Weng, Jianping

Prevalence of Diabetes among Men and Women in China

Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 3,031

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 1,008

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 780

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 323

Incidence of type 1 diabetes in China, 2010-13: population based study

Weng, J., Zhou, Z., Guo, L., Zhu, D., Ji, L., Luo, X., Mu, Y., & Jia, W. (2018) · BMJ

Diabetes and associated disordersDiabetes Management and Research

Cited by 316

Standards of care for type 2 diabetes in China

Weng, J., Ji, L., Jia, W., Lu, J., Zhou, Z., Zou, D., Zhu, D., Chen, L., Chen, L., Guo, L., et al. (2016) · Diabetes/Metabolism Research and Reviews

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

Ma, X., Liu, Z., Ilyas, I., Little, P. J., Kamato, D., Sahebka, A., Chen, Z., Luo, S., Zheng, X., Weng, J., et al. (2021) · International Journal of Biological Sciences

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 299

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., et al. (2014) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 296

GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1

Xu, F., Lin, B., Zheng, X., Chen, Z., Cao, H., Xu, H., Liang, H., & Weng, J. (2016) · Diabetologia

Adipose Tissue and MetabolismSirtuins and Resveratrol in Medicine

Cited by 157

Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: From pharmacology to pre-clinical and clinical therapeutics

Liu, Z., Ma, X., Ilyas, I., Zheng, X., Luo, S., Little, P. J., Kamato, D., Sahebkar, A., Wu, W., Weng, J., et al. (2021) · Theranostics

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 155

SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis

Xu, F., Li, Z., Zheng, X., Liu, H., Liang, H., Xu, H., Chen, Z., Zeng, K., & Weng, J. (2014) · Diabetes

Liver Disease Diagnosis and TreatmentSirtuins and Resveratrol in Medicine

Cited by 114

GLP‐1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in Mice

Zhang, E., Xu, F., Liang, H., Yan, J., Xu, H., Li, Z., Wen, X., & Weng, J. (2015) · American Journal of Reproductive Immunology

Sperm and Testicular FunctionReproductive Biology and Fertility

Cited by 73

Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study

Zhou, X., Ji, L., Ran, X., Su, B., Ji, Q., Pan, C., Weng, J., Ma, C., Hao, C., Zhang, D., et al. (2016) · PLOS ONE

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 56

Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection

Tao, W., Wang, X., Zhang, G., Guo, M., Ma, H., Zhao, D., Sun, Y., He, J., Liu, L., Zhang, K., et al. (2021) · Protein & Cell

SARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies

Cited by 42

Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice

Xu, F., Cao, H., Chen, Z., Gu, H., Guo, W., Lin, B., & Weng, J. (2020) · International Journal of Obesity

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 31

Comparing the glycaemic outcomes between real‐time continuous glucose monitoring ( rt‐CGM ) and intermittently scanned continuous glucose monitoring ( isCGM ) among adults and children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Zhou, Y., Sardana, D., Kuroko, S., Haszard, J. J., de Block, M. I., Weng, J., Jefferies, C., & Wheeler, B. J. (2024) · Diabetic Medicine

Diabetes Management and ResearchDiabetes Management and Education

Cited by 25

Gender-differential effects on blood glucose levels between acarbose and metformin in Chinese patients with newly diagnosed type 2 diabetes: a sub-analysis of the MARCH trial

Li, J., Li, J., Shan, Z., Yang, W., Liu, J., Tian, H., Zhou, Z., Ji, Q., Weng, J., Jia, W., et al. (2021) · Endocrine Journal

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 16

Comparative effectiveness and safety of different basal insulins in a real-world setting

Ji, L., Zhang, P., Zhu, D., Lu, J., Guo, X., Wu, Y., Li, X., Ji, J., Jia, W., Yang, W., et al. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 13

PEDF Expression Is Inhibited by Insulin Treatment in Adipose Tissue via Suppressing 11β-HSD1

Zhou, Y., Xu, F., Deng, H., Bi, Y., Sun, W., Zhao, Y., Chen, Z., & Weng, J. (2013) · PLoS ONE

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 12